Frequently Asked Question
Not exactly. The review is about whether pharmacies may legally compound these substances — building a legal, regulated pathway, not adding a new prohibition. Today most already have no cleared legal channel. Follow the status on the tracker.
Get notified
The vote is advisory. The decision that shapes access comes later - if and when the FDA opens a formal public comment window. Most people never hear it opened. Join the list and we'll tell you the instant it does, with step-by-step instructions to file a comment that counts.
